LSTA
LSTA
NASDAQ · Biotechnology

Lisata Therapeutics Inc

$5.02
+0.00 (+0.00%)
As of Mar 29, 10:51 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +535.1% upside
Low Target $19.01
Average Target $31.88
High Target $45.37
Current Price $5.02
Current
$5.02
Target
$31.88
$19.01 $31.88 avg $45.37
Scenario Analysis
Bear Case
$19.01
278.7%
Low target
Base Case
$31.88
+535.1%
Avg target
Bull Case
$45.37
+803.8%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$5.07
-1.0% from high
52-Week Low
$1.81
+177.3% from low
Target vs 52W High
$31.88
+528.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%